FDA has proposed a rule to streamline registration for certain distributed drug manufacturing sites and ‌clarify reporting requirements for some foreign production facilities, as part ‌of its efforts ...
The proposed rule would allow multiple manufacturing units at different locations to register as one establishment.
In the wake of the Food & Drug Administration’s (FDA) ambitious unified agenda, on July 13, 2026, the agency published a proposed rule aiming to align its regulatory frameworks with “how distributed ...
Silver Spring, MD, July 10, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today issued a proposed rule that, if finalized, would create a streamlined registration pathway for ...
US FDA proposes a new rule to simplify drug manufacturer registration, improve supply chain transparency and strengthen oversight of global pharmaceutical networks.
On July 13, the US Food and Drug Administration (FDA) proposed a new rule that would fundamentally change how certain drug manufacturers ...
The US Food and Drug Administration (FDA) on Friday outlined a set of proposed reforms to advance modern manufacturing methods and increase supply chain visibility. In a proposed rule, the agency said ...
The FDA's new website and regulatory overhaul aim to close a loophole that lets foreign factories hide raw drug materials from U.S. supply chain oversight.
July 10 (Reuters) - The U.S. FDA on Friday proposed a rule to streamline registration requirements for certain drug manufacturers that operate through a central hub and multiple production facilities, ...
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly July 10 (Reuters) - The U.S. FDA has proposed a rule ...